Genopathy
Gene-Disorder Association · Article
Gene
CYP2A6
Cytochrome P450 Family 2 Subfamily A Member 6
Disorder
Drug Metabolism, Altered, Cyp2a6-Related
First reported 2002
Key publication · disorder A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.Pharmacogenetics · 2002
Manually curated
Association Review

In brief

The association between CYP2A6 (Cytochrome P450 Family 2 Subfamily A Member 6) and Drug Metabolism, Altered, Cyp2a6-Related is a manually-curated gene–disease association, drawing on a single expert-curated source, which records a known molecular basis and a susceptibility locus.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CYP2A6

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Drug Metabolism, Altered, Cyp2a6-Related

The disorder

2 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Provenance

References & sources

2 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access